| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574574 | Journal of Stroke and Cerebrovascular Diseases | 2016 | 6 Pages |
Abstract
Baseline characteristics, presenting symptoms, and response to dysphagia screen identify a subgroup of patients who are more likely to have an unfavorable outcome. Whether IV tPA treatment can improve the outcome in this subgroup of patients needs to be evaluated in a randomized placebo-controlled trial.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Gaurav BS, Nibal MD, Deborah RN, MHA, CCM, SCRN, Katja MSN, RN, CNRN, Susan RN, MSN, CNRN, Cynthia RN, CNRN, SCRN, Kerrin RN, MSN, MPH, Joshua RN, MSN, CCRN, Michael MD, Moges Seymour MD, MS, MPH, James RN, FNP, MSN, Fadi MD,